Citation Impact
Citing Papers
miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
2013
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
PRL-3 Down-regulates PTEN Expression and Signals through PI3K to Promote Epithelial-Mesenchymal Transition
2007
A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer
2006
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
2014
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
2019 Standout
Drugs from the deep: marine natural products as drug candidates
2003 Standout
Inflammation and cancer: advances and new agents
2015
Regulation of microRNA function in animals
2018 Standout
Protective effects of thymol against nephrotoxicity induced by cisplatin with using99mTc-DMSA in mice
2014
Towards better clinical prediction models: seven steps for development and an ABCD for validation
2014 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
The combination of yondelis and cisplatin is synergistic against human tumor xenografts
2003
RNA-based recognition and targeting: sowing the seeds of specificity
2017 StandoutNobel
Marine natural products
1990 Standout
Drug development from marine natural products
2008 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma
2003
Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
2009
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2013
Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
2013
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
2015
Global mapping of miRNA-target interactions in cattle (Bos taurus)
2017 StandoutNobel
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer
2012
MicroRNAs in cancer: biomarkers, functions and therapy
2014 Standout
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
2015
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity
2015 StandoutNobel
Poor performance of clinical prediction models: the harm of commonly applied methods
2017
A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration
2016 StandoutNobel
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
2011
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone
2010
Fibroblasts as architects of cancer pathogenesis
2012
Systems biology of cisplatin resistance: past, present and future
2014
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
2013
EMT: 2016
2016 Standout
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Prognostic Role of Tissue and Circulating MicroRNA-200c in Malignant Tumors: a Systematic Review and Meta-Analysis
2015
Clinicopathological characteristics of patients with synchronous primary endometrial and ovarian cancers: A review of 43 cases
2012
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment
2016
miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence
2017 StandoutNobel
Endometriosis: pathogenesis and treatment
2013 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Unraveling the two entities of endometrioid ovarian cancer: A single center clinical experience
2012
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
2013
Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
2017 Standout
PRL3 Promotes Cell Invasion and Proliferation by Down-regulation of Csk Leading to Src Activation
2006
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Inflammatory pathways in female reproductive health and disease
2009
Evaluation of Markers and Risk Prediction Models
2013
Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects
2021
Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
2004
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Patterns of recurrence and survival after abdominal versus laparoscopic/robotic radical hysterectomy in patients with early cervical cancer
2015
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Sponge-Associated Microorganisms: Evolution, Ecology, and Biotechnological Potential
2007 Standout
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
Role of aberrant glycosylation in ovarian cancer dissemination
2014
Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer
2013
PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer
2018
Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743.
2002
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Marine Microalgae with Anti-Cancer Properties
2018 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Alkaloids from Marine Ascidians
2011
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
2018 Standout
An overview of long non-coding RNAs in ovarian cancers
2016
Graphene family, and their hybrid structures for electromagnetic interference shielding applications: Recent trends and prospects
2021 Standout
Drug Resistance in Cancer: An Overview
2014 Standout
miR‐181a mediates TGF ‐β‐induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer
2014
Chemical Glycoproteomics
2016 StandoutNobel
Works of Robert Fruscio being referenced
Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis
2017
External Validation of Diagnostic Models to Estimate the Risk of Malignancy in Adnexal Masses
2011
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
2014
Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor’s proangiogenic microenvironment
2011
Synchronous early‐stage endometrial and ovarian cancer
2008
Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group
2010
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
2010
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
2012
Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer
2011
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
2011
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
2012
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review
2012
Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: Analysis of surgical and oncological outcome
2008
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery*
2007
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model
2019
ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.
2013
Unique Features of the Mode of Action of ET-743
2002
PRL-3 Phosphatase Is Implicated in Ovarian Cancer Growth
2005